Unfortunately, there is a real lack of studies comparing one triptan medication to another but in the absence of head-to-head studies, this is what we do know about triptans, one of the most commonly used …
Read the full story »New research has linked a brain hormone to panic attacks. Called orexin, this hormone is secreted in abnormally high amounts in those who suffer from panic attacks. Previous research showed that orexin regulates vigilance, arousal, wakefulness and …
Imagine being able to find metastatic dormant cancer cells far too small to be detected by MRI, CT or PET scans. Research being conducted at the University of Pennsylvania has successfully demonstrated this ability using animal models. …
The idea of preventing or even treating cancer with a vaccine has always faced a particular challenge: cancer cells originate in our bodies and a vaccine wouldn’t be able to distinguish good cells from bad ones. …
I recently had a patient ask about the use of antioxidants during chemotherapy. Although my patient didn’t have cancer – her family member did – I remembered reading about this when my mother was being …
Illustration shows where DVTs commonly form
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has been funding research into treatment of deep vein thrombosis (DVTs) that doesn’t rely on the use of drug therapy such …
The CDC released statistics on the 10 most diagnosed cancers affecting women in this country as of 2006, the most recent year for which statistics are available.
Breast cancer leads the way, by more than double, …
Imagine being able to deliver a medication to the exact spot in the body where it could do the most good. Such a delivery system already exists and it is also used to help scientists …
Concussion: Why It Matters and How to Diagnose It
The force of the impact causes the brain to strike the inner surface of the skull causing the brain to rebound and strike the back inner surface of the skull. This leads to swelling and …
Provenge, the first therapeutic vaccine, has been approved by the FDA for metastatic prostate cancer and will be available within the next year to patients who meet the criteria for advanced prostate cancer. The vaccine …